Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
PeriOperative ISchemic Evaluation-2 Trial (POISE-2)
This study is currently recruiting participants.
Verified June 2013
by McMaster University
Study NCT01082874 Information provided by McMaster University
First Received on March 8, 2010. Last Updated on June 12, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Disease
Additional conditions recognized in this trial
Cardiovascular Diseases
Interventions listed in this trial
Active Clonidine
Placebo Clonidine
Active ASA
Placebo ASA
Additional drug interventions recognized in this trial
Aspirin
Clonidine
Salicylates
Salicylic Acid
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Analgesics
Analgesics, Non-Narcotic
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antifungal Agents
Antihypertensive Agents
Antipyretics
Antirheumatic Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Keratolytic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Sympatholytics
Therapeutic Uses
Sponsors listed in this trial
Hamilton Health Sciences Corporation
McMaster University
Back to top of Main Content
